1 |
Deng, C. X. 2001. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Mutat Res, 477, 183-189
DOI
ScienceOn
|
2 |
Huber, L. J., Yang, T. W., Sarkisian, C. J., Master, S. R., Deng, C. X., and Chodosh, L. A 2001. Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci. Mol Cell Biol, 21, 4005-4015
DOI
ScienceOn
|
3 |
Moynahan, M E., Cui, T. Y., and Jasin, M. 2001. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res, 61, 4842-4850
|
4 |
Wang, X., Peterson, C. A., Zheng, H., Nairn, R. S., Legerski, R. J., and Li, L. 2001. Involvement of nucleotide excision repair in a recombination- independent and error-prone pathway of DNA interstrand cross-link repair. Mol Cell Biol, 21, 713-720
DOI
ScienceOn
|
5 |
Yun, J., Zhong, Q., Kwak, J. Y., and Lee, W. H. 2005. Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest. Oncogene, 24, 4009-4016
DOI
ScienceOn
|
6 |
Yu, V. P., Koehler, M., Steinlein, C., Schmid, M., Hanakahi, L. A, van Gool, A. J., West, S. C., and Venkitaraman, A R. 2000. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev, 14, 1400-1406
|
7 |
Ting, N. S., and Lee, W. H. 2004. The DNA double-strand break response pathway: becoming more BRCAish than ever. DNA Repair (Amst), 3, 935-944
DOI
ScienceOn
|
8 |
Zheng, L., Li, S., Boyer, T. G., and Lee, W. H. 2000. Lessons learned from BRCA1 and BRCA2. Oncogene, 19, 6159-6175
DOI
ScienceOn
|
9 |
Zheng, L., Pan, H., Li, S., Flesken-Nikitin, A, Chen, P. J., Boyer, T. G., and Lee, W. H. 2000. Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol Cell, 6, 757-768
DOI
ScienceOn
|
10 |
Xu, X., Weaver, Z., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., and Deng, C. X. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell, 3, 389-395
DOI
ScienceOn
|
11 |
Aprelikova, O., Pace, A J., Fang, B., Koller, B. H., and Liu, E. T. 2001. BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J Biol Chem, 276, 25647-25650
|
12 |
Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA, 90, 8392-8396
|
13 |
McHugh, P. J., Sones, W. R., and Hartley, J. A 2000. Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol Cell Biol, 20, 3425-3433
DOI
ScienceOn
|
14 |
Metzler, M. 1986. DNA adducts of medicinal drugs: some selected examples. J Cancer Res Clin Oncol, 112, 210-215
DOI
|
15 |
Dronkert, M L., and Kanaar, R. 2001. Repair of DNA interstrand cross-links. Mutat Res, 486, 217-247
DOI
ScienceOn
|
16 |
Berardini, M, Mackay, W., and Loechler, E. L. 1997. Evidence for a recombination-independent pathway for the repair of DNA interstrand cross-links based on a site-specific study with nitrogen mustard. Biochemistry, 36, 3506-3513
DOI
ScienceOn
|
17 |
Bhattacharyya, A, Ear, U. S., Koller, B. H., Weichselbaum, R. R., and Bishop, D. K. 2000. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem, 275, 23899-23903
DOI
ScienceOn
|
18 |
Rothfuss, A, and Grompe, M. 2004. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol, 24, 123-134
DOI
ScienceOn
|